Immune Checkpoint Inhibitors in Small-Cell Lung Cancer

1 Views
administrator
administrator
07/04/23

Mark Socinski, MD; Roy Herbst, MD, PhD; and Naiyer Rizvi, MD, discuss the excitement over PD-1 inhibitors in non-small–cell lung cancer. The data for pembrolizumab and that for nivolumab plus ipilimumab were equally impressive.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next